GO:0019770 IgG receptor activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0019770 (IgG receptor activity) is a molecular function defined as combining with an immunoglobulin of an IgG isotype via the Fc region and transmitting a signal across the membrane to initiate a change in cell activity.
The best-characterized IgG receptors are Fc gamma receptors (FcγRs), including the inhibitory FcγRIIB and activating receptors such as FcγRI, FcγRIIA, FcγRIIIA, and the neonatal Fc receptor FcRn [1,5].
IgG receptor activity is central to antibody effector functions, including antibody-dependent cellular cytotoxicity (ADCC), phagocytosis, and cross-presentation of IgG-containing immune complexes [5,8].
Dysregulated IgG receptor signaling contributes to autoimmune disease, obesity-induced insulin resistance, neuroinflammation, and impaired bacterial clearance [2,3,4].
IgG receptor activity can be studied with CRISPR knockout, point-mutation, knock-in, and overexpression models, combined with functional assays such as ADCC, phagocytosis, and signaling readouts [5,8].
The inhibitory receptor FcγRIIB provides a critical checkpoint that limits activating IgG receptor signals, making it a key target for therapeutic modulation [1,4].

Description

GO:0019770, IgG receptor activity, is a molecular function that enables a cell to bind an immunoglobulin of the IgG isotype through its Fc region and convert that binding event into an intracellular signal [1,5]. This activity is fundamental to how antibodies bridge humoral immunity and cellular effector responses, allowing IgG-coated targets to be recognized, internalized, or destroyed [5,8]. Because IgG is the most abundant antibody class in human circulation, receptors with this activity are positioned at the interface of host defense, inflammation, and tissue homeostasis [1,7]. Researchers study IgG receptor activity to understand antibody effector mechanisms, to engineer therapeutic antibodies with optimized Fc regions, and to dissect how inhibitory and activating Fc gamma receptors balance immune activation [1,5]. The term is also relevant beyond classical immunity: IgG receptors on endothelial cells and macrophages have been implicated in metabolic and neuroinflammatory processes [2,3,4]. In this article, we summarize the definition, mechanism, key genes, disease links, and experimental models for GO:0019770, with a focus on how CRISPR-based approaches can be used to interrogate this function.

IgG receptor activity At A Glance

GO ID GO:0019770
GO term IgG receptor activity
Ontology molecular_function
Synonym none
Definition Combining with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
Major function Binding the Fc region of IgG and converting this binding into intracellular signals that drive effector responses such as ADCC, phagocytosis, and cytokine release [1,5].
Representative receptors FcγRIIB (inhibitory), FcγRI, FcγRIIA, FcγRIIIA, FcRn [1,5].
Cellular context Expressed on immune cells (macrophages, NK cells, B cells, dendritic cells) and on endothelial cells [1,3,4].
Disease relevance Autoimmunity, obesity-induced insulin resistance, neuroinflammation, and impaired bacterial clearance [2,3,4].

What Is GO:0019770?

According to the Gene Ontology, GO:0019770 (IgG receptor activity) is a molecular function defined as combining with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. In practical terms, a protein with this activity must (1) bind the Fc portion of IgG, (2) span or associate with the plasma membrane, and (3) couple ligand binding to downstream intracellular signaling [1,5]. This distinguishes IgG receptors from soluble IgG-binding proteins that do not signal, and from receptors for other antibody isotypes such as IgE or IgA.

Why Is IgG receptor activity Important in Cell Biology?

IgG receptor activity is important because it determines how antibodies translate into cellular outcomes. Activating IgG receptors can trigger pathogen clearance and tumor cell killing, while the inhibitory receptor FcγRIIB dampens these responses to prevent excessive inflammation [1,5]. The balance between activating and inhibitory IgG receptor signals influences vaccine efficacy, autoimmune pathology, and the success of therapeutic antibodies [1,3,7]. Moreover, IgG receptors are not limited to classical immune cells; their expression on endothelial cells and in the brain links IgG recognition to metabolic and neuropsychiatric conditions [2,4]. Understanding GO:0019770 therefore has broad implications for immunology, oncology, metabolism, and neuroscience.
IgG receptor activity mediates antibody-dependent cellular cytotoxicity (ADCC), a key mechanism of therapeutic monoclonal antibodies.
It enables phagocytosis of IgG-opsonized pathogens and immune complexes, contributing to host defense [3,7].
The inhibitory receptor FcγRIIB sets a threshold for immune activation and prevents autoimmunity.
IgG receptor signaling on endothelial cells can promote obesity-induced insulin resistance.
Altered IgG receptor levels in the midbrain have been associated with schizophrenia.
Cross-presentation of IgG-containing immune complexes is important for antigen presentation and vaccine responses.
IgG receptors are targets for engineering improved antibody therapeutics with tailored effector functions.
CRISPR screens and knockout models can identify genes that regulate IgG receptor activity [5,8].

Molecular Mechanism of IgG receptor activity

IgG Fc recognition and binding
In simple terms: The receptor grabs the tail of an antibody.
The first step in IgG receptor activity is specific binding of the Fc region of IgG. Receptors such as FcγRIIB and FcγRIIIA possess extracellular immunoglobulin-like domains that recognize the Fc portion of IgG in a manner dependent on antibody subclass and glycosylation state [1,4]. This binding is the trigger for all downstream signaling and determines which IgG-coated targets are engaged.
Receptor clustering and membrane signaling
In simple terms: Multiple receptors come together to send a signal inside the cell.
Upon IgG binding, receptors cluster on the plasma membrane, enabling trans-phosphorylation of associated signaling motifs. Activating receptors such as FcγRIIA and FcγRIIIA signal through immunoreceptor tyrosine-based activation motifs (ITAMs), while the inhibitory receptor FcγRIIB signals through an immunoreceptor tyrosine-based inhibition motif (ITIM) [1,5]. This clustering is essential for transmitting the signal from one side of the membrane to the other, as required by the GO definition.
Activating versus inhibitory signaling
In simple terms: Some receptors say go, others say stop.
Activating IgG receptors recruit kinases such as Syk, leading to calcium flux, cytoskeletal rearrangement, and effector functions including ADCC and phagocytosis. In contrast, FcγRIIB recruits phosphatases such as SHIP that counteract activating signals, thereby limiting immune responses. The balance between these opposing signals determines the net cellular outcome of IgG receptor engagement [1,5].
Downstream effector responses
In simple terms: The signal makes the cell attack, eat, or present antigens.
IgG receptor signaling can lead to diverse effector outputs. In NK cells, it triggers ADCC and cytokine release. In macrophages, it promotes phagocytosis and bacterial capture. In dendritic cells, it facilitates cross-presentation of IgG-containing immune complexes to T cells. These outcomes are context-dependent and shaped by the specific receptor repertoire and cellular environment [5,7,8].
Regulation by glycosylation and pentraxins
In simple terms: Sugar tags and other proteins can tune the receptor's activity.
The glycosylation state of IgG, particularly sialylation, can modulate binding to FcγRIIB and influence receptor activation. Pentraxins such as C-reactive protein and serum amyloid P component can also interact with Fc receptors and shape immune responses. These regulatory layers add complexity to IgG receptor activity and are important for understanding disease-associated dysregulation [4,7].

Key Genes Involved in GO:0019770 IgG receptor activity

The following genes encode proteins that mediate or regulate IgG receptor activity, including Fc gamma receptors and associated signaling molecules.
GeneMajor RoleResearch Relevance
FCGR2BInhibitory IgG receptor (FcγRIIB) that dampens activating signals via ITIMAutoimmunity, insulin resistance, therapeutic target [1,4]
FCGR1AHigh-affinity activating IgG receptor (FcγRI)ADCC, phagocytosis, immune complex clearance
FCGR2AActivating IgG receptor (FcγRIIA) with ITAMAntibody effector function, bacterial clearance [3,5]
FCGR3AActivating IgG receptor (FcγRIIIA) on NK cellsADCC, therapeutic antibody response
FCGR3BActivating IgG receptor (FcγRIIIB) on neutrophilsImmune complex clearance, inflammation
FCGRTNeonatal Fc receptor (FcRn) that binds IgG and regulates its half-lifeIgG homeostasis, drug delivery
SYKKinase downstream of activating IgG receptorsITAM signaling, ADCC
SHIP1Phosphatase recruited by FcγRIIB to inhibit signalingInhibitory signaling, autoimmunity
C1QAComplement component that interacts with IgG immune complexesCross-presentation, immune complex handling
CRPPentraxin that can bind Fc receptors and modulate responsesInflammation, Fc receptor regulation
APCSSerum amyloid P component, a pentraxinFc receptor interactions, innate immunity
ITGB2Integrin involved in leukocyte adhesion during IgG receptor-mediated phagocytosisPhagocytosis, immune cell recruitment
RAC1Small GTPase regulating actin dynamics during phagocytosisCytoskeletal rearrangement, phagocytosis
CDC42Small GTPase involved in Fc receptor-mediated uptakePhagocytosis, membrane remodeling
PLCG2Phospholipase C gamma 2 downstream of ITAM signalingCalcium flux, effector functions
PIK3CDPhosphoinositide 3-kinase delta, involved in Fc receptor signalingSignal transduction, immune cell activation
PRKCDProtein kinase C delta, downstream of Fc receptorsInflammatory signaling, macrophage function
VAV1Guanine nucleotide exchange factor for Rac1Cytoskeletal reorganization, phagocytosis

How Is IgG receptor activity Regulated?

IgG receptor activity is regulated at multiple levels. The inhibitory receptor FcγRIIB provides a negative feedback loop that limits activating signals through its ITIM and recruitment of phosphatases such as SHIP1. Glycosylation of IgG, particularly sialylation, can alter binding affinity for FcγRIIB and thereby modulate receptor activation. Pentraxins can also influence Fc receptor-mediated responses by interacting with immune complexes or receptors. In addition, the expression levels of Fc gamma receptors are regulated by cytokines and inflammatory cues, which can shift the balance between activating and inhibitory signaling [1,5]. These regulatory mechanisms are critical for preventing excessive inflammation and maintaining immune homeostasis [1,4,7].

IgG receptor activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
FCGR2BAutoimmunity, insulin resistanceKnockout or point-mutation in macrophages/endothelial cells [1,4]
FCGR3AImpaired ADCC in cancer therapyKnock-in of variant alleles in NK cells
FCGR2ABacterial infection susceptibilityKnockout in macrophages, bacterial challenge
FCGRTIgG half-life and drug deliveryKnockout in mice or cell lines
FCGR2BNeuroinflammation in schizophreniaOverexpression in microglial models
Autoimmunity and inflammatory disease
Dysregulated IgG receptor activity is implicated in autoimmune conditions. The inhibitory receptor FcγRIIB normally restrains activating signals, and loss of its function can predispose to autoimmunity. Conversely, excessive activating IgG receptor signaling can drive tissue damage in inflammatory diseases [1,7]. Understanding these pathways is essential for developing therapies that target Fc gamma receptors.
Obesity-induced insulin resistance
Hyposialylated IgG can activate endothelial FcγRIIB, promoting obesity-induced insulin resistance. This finding links IgG receptor activity to metabolic disease and suggests that modulating IgG glycosylation or FcγRIIB signaling could improve insulin sensitivity.
Neuroinflammation and schizophrenia
Increased levels of a pro-inflammatory IgG receptor have been observed in the midbrain of people with schizophrenia, suggesting a role for IgG receptor activity in neuroinflammation and psychiatric disorders. This highlights the importance of understanding how IgG receptors function in the central nervous system.
Infection and vaccine responses
IgG receptor activity is critical for vaccine-elicited capture of invasive bacteria by liver macrophages and sinusoidal endothelial cells. Cross-presentation of IgG-containing immune complexes also shapes T cell responses and vaccine efficacy. These roles make IgG receptors important for host defense and immunotherapy [3,8].

From IgG receptor activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of FCGR2B enhance activating IgG receptor signaling?FCGR2B knockout cell line (e.g., macrophages)
Does a point mutation in FCGR2A alter ligand binding?Point-mutation knock-in via CRISPR
Can FcγRIIB signaling be rewired by altering ITIM tyrosines?Knock-in of mutant ITIM
How does FCGR3A overexpression affect ADCC?Overexpression in NK cell lines
What is the role of FCGRT in IgG transcytosis?Tagged knock-in of FCGRT
Which genes regulate IgG receptor-mediated phagocytosis?CRISPR library screening in macrophages [3,8]

How to Study the IgG receptor activity Process

MethodWhat It MeasuresTypical Application
ADCC assayCytotoxicity of NK cells against IgG-coated targetsTherapeutic antibody evaluation
Phagocytosis assayUptake of IgG-opsonized particlesMacrophage function, bacterial clearance
ImmunoblottingPhosphorylation of signaling proteinsITAM/ITIM pathway analysis
Calcium flux assayIntracellular calcium mobilizationActivating receptor signaling
CRISPR knockout screenGenes required for IgG receptor functionDiscovery of novel regulators [3,8]
Flow cytometryReceptor expression and bindingCell surface phenotyping
Live-cell imagingReceptor clustering and internalizationSpatiotemporal dynamics
Cytokine release assayInflammatory cytokine productionEffector response quantification
Functional assays for IgG receptor activity
ADCC and phagocytosis assays are standard methods to measure IgG receptor activity. ADCC can be assessed using NK cells or engineered iNK-CD64/16A cells. Phagocytosis of IgG-opsonized targets can be quantified by flow cytometry or microscopy. These assays provide direct readouts of receptor function [5,8].
Signaling and biochemical analysis
Phosphorylation of ITAM/ITIM motifs and downstream kinases can be analyzed by immunoblotting and phosphoproteomics [1,5]. Calcium flux assays and cytokine release measurements further characterize signaling outcomes. These methods help dissect activating versus inhibitory pathways.
Genetic screens and CRISPR models
CRISPR knockout and library screens can identify genes that regulate IgG receptor activity [3,8]. For example, genome-wide screens in macrophages can reveal novel regulators of phagocytosis. Knock-in of specific mutations allows structure-function studies [1,5].
Imaging and spatial analysis
Live-cell imaging and confocal microscopy can visualize receptor clustering, internalization, and cytoskeletal rearrangements during IgG receptor activation [3,5]. These techniques provide spatial and temporal resolution of receptor dynamics.

How CRISPR Can Be Used to Study GO:0019770 IgG receptor activity

Knockout

CRISPR knockout of FCGR2B or activating Fc gamma receptors can reveal their specific contributions to IgG receptor activity. For example, FCGR2B knockout macrophages show enhanced activating signaling, confirming its inhibitory role. Knockout of FCGR3A in NK cells reduces ADCC.

Point Mutation

Point mutations in ITIM or ITAM tyrosines can dissect signaling motifs. CRISPR-mediated point mutation of FCGR2B ITIM tyrosines can abolish its inhibitory function. Similarly, mutations in FCGR2A can alter ligand binding affinity.

Knock-in

Knock-in of tagged receptors (e.g., GFP-FCGR2B) allows real-time imaging of receptor trafficking. Knock-in of human FCGR variants into mouse models can humanize IgG receptor responses for preclinical studies.

Overexpression

Overexpression of activating receptors such as FCGR3A in NK cell lines can enhance ADCC and facilitate functional studies. Overexpression of FCGR2B can suppress signaling and model inhibitory states.

How EDITGENE Supports IgG receptor activity Research

Researchers studying IgG receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or disease. EDITGENE provides CRISPR-based cell model services to enable precise genetic interrogation of GO:0019770 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for IgG receptor activity research.

Frequently Asked Questions About IgG receptor activity

IgG receptor activity (GO:0019770) is a molecular function where a receptor binds the Fc region of IgG and transmits a signal across the membrane to change cell activity [1,5].
Key genes include FCGR2B, FCGR1A, FCGR2A, FCGR3A, FCGR3B, FCGRT, and downstream signaling molecules such as SYK and SHIP1 [1,5,7].
Activating receptors signal through ITAMs to trigger effector functions, while inhibitory receptors like FcγRIIB signal through ITIMs to dampen activation [1,5].
Common methods include ADCC assays, phagocytosis assays, immunoblotting for phosphorylated signaling proteins, and calcium flux assays [5,3].
Autoimmunity, obesity-induced insulin resistance, neuroinflammation, and impaired bacterial clearance have been associated with altered IgG receptor function [1,2,3,4].
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect IgG receptor function [1,5,8].
FcγRIIB is the inhibitory IgG receptor that limits activating signals and is encoded by FCGR2B.
Sialylation of IgG can modulate binding to FcγRIIB and influence receptor activation, as seen in obesity-induced insulin resistance.
Activating IgG receptors on NK cells, such as FcγRIIIA, trigger ADCC against antibody-coated target cells.
IgG receptors are expressed on macrophages, NK cells, B cells, dendritic cells, neutrophils, and endothelial cells [1,3,4,5].

Conclusion

GO:0019770 (IgG receptor activity) is a fundamental molecular function that links antibody recognition to cellular responses. Its dysregulation contributes to autoimmune, metabolic, and neuroinflammatory diseases, making it a key area of biomedical research [1,2,3,4]. CRISPR-based models offer precise tools to interrogate the genes and mechanisms underlying IgG receptor activity, and EDITGENE provides comprehensive services to support such studies [5,8].

References

  1. 1. Xu Z et al.. 2018. The Unique Inhibitory IgG Receptor--FcγRIIb.. Protein Pept Lett 25(11):966-972 PMID: 30370842
  2. 2. Petty A et al.. 2022. Increased levels of a pro-inflammatory IgG receptor in the midbrain of people with schizophrenia.. J Neuroinflammation 19(1):188 PMID: 35841099
  3. 3. Wang J et al.. 2023. Liver macrophages and sinusoidal endothelial cells execute vaccine-elicited capture of invasive bacteria.. Sci Transl Med 15(727):eade0054 PMID: 38117903
  4. 4. Tanigaki K et al.. 2018. Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance.. J Clin Invest 128(1):309-322 PMID: 29202472
  5. 5. Walcheck B et al.. 2019. iNK-CD64/16A cells: a promising approach for ADCC?. Expert Opin Biol Ther 19(12):1229-1232 PMID: 31510805
  6. 7. Lu J et al.. 2018. Pentraxins and Fc Receptor-Mediated Immune Responses.. Front Immunol 9:2607 PMID: 30483265
  7. 8. Baker K et al.. 2013. Cross-presentation of IgG-containing immune complexes.. Cell Mol Life Sci 70(8):1319-34 PMID: 22847331
Contact Us
*
*
*
*
How did you hear about us: